Athira Pharma Investors

18 investors on Angel Roster list Athira Pharma in their portfolio. Most are venture capital firms and hedge funds, the most common stage is Series B and the largest groups are based in the United States and Canada.

Investors are matched on the company name in their portfolio, so companies that share the name Athira Pharma can appear together.

Investors listed
18
With verified email
44%
Most common stage
Series B
Top location
United States

Updated October 13, 2026 · How we compile this data

Top 18 Athira Pharma investors

The most complete profiles first. Showing 18 of 18.

  • Jonathan LeffVerified

    Venture Capital, Investor · United States

    SeedSeries BHealth CareGeneticsWomen FoundedLife Science

    Portfolio: ENYO Pharma, Y-mAbs Therapeutics, NuCana, Histogenics and 66 more

    Verified email available

  • Joshua KennedyVerified

    Hedge Fund, Venture Capital, Investor · United States

    Series BHealth CareGeneticsInvestment ManagementLife Science

    Portfolio: AveXis, Frequency Therapeutics, Roivant Sciences, Magnolia Medical Technologies and 28 more

    Verified email available

  • Sarah BhagatVerified

    Venture Capital, Investor · United States

    SeedHealth CareGeneticsWomen FoundedLife Science

    Portfolio: ENYO Pharma, Y-mAbs Therapeutics, NuCana, Histogenics and 63 more

    Verified email available

  • Stephanie A. SirotaVerified

    Hedge Fund, Venture Capital, Investor · United States

    Series BHealth CareGeneticsEnterprise SoftwareInvestment Management

    Portfolio: AveXis, Frequency Therapeutics, Roivant Sciences, Magnolia Medical Technologies and 28 more

    Verified email available

  • Alan ColowickVerified

    Venture Capital · United States

    Health CareGeneticsWomen FoundedLife Science

    Portfolio: ENYO Pharma, Y-mAbs Therapeutics, NuCana, Histogenics and 63 more

    Verified email available

  • Jason PittsVerified

    Venture Capital · United States

    Health CareGeneticsWomen FoundedLife Science

    Portfolio: ENYO Pharma, Y-mAbs Therapeutics, NuCana, Histogenics and 63 more

    Verified email available

  • Mike PowellVerified

    Venture Capital · United States

    Health CareGeneticsWomen FoundedLife Science

    Portfolio: ENYO Pharma, Y-mAbs Therapeutics, NuCana, Histogenics and 63 more

    Verified email available

  • Maha Katabi, PhD, CFA

    Hedge Fund, Venture Capital, Investor · Canada

    SeedHealth CareGeneticsWomen FoundedInvestment Management

    Portfolio: ENYO Pharma, Y-mAbs Therapeutics, NuCana, Histogenics and 64 more

    Contact details available

  • Naveen Yalamanchi

    Hedge Fund, Venture Capital, Investor · United States

    Series BHealth CareGeneticsInvestment ManagementLife Science

    Portfolio: AveXis, Frequency Therapeutics, Roivant Sciences, Magnolia Medical Technologies and 28 more

    Contact details available

  • Perry Nisen

    Venture Capital, Investor · United States

    SeedHealth CareGeneticsWomen FoundedLife Science

    Portfolio: ENYO Pharma, Y-mAbs Therapeutics, NuCana, Histogenics and 63 more

    Contact details available

  • Piratip Pratumsuwan

    Hedge Fund, Venture Capital, Investor · United States

    Series BHealth CareGeneticsInvestment ManagementLife Science

    Portfolio: AveXis, Frequency Therapeutics, Roivant Sciences, Magnolia Medical Technologies and 29 more

    Contact details available

  • Roderick Wong

    Hedge Fund, Venture Capital, Investor · United States

    Series BHealth CareGeneticsInvestment ManagementLife Science

    Portfolio: AveXis, Frequency Therapeutics, Roivant Sciences, Magnolia Medical Technologies and 29 more

    Contact details available

  • Sabera Loughran

    Hedge Fund, Venture Capital, Investor · United States

    Series BHealth CareGeneticsInvestment ManagementLife Science

    Portfolio: AveXis, Frequency Therapeutics, Roivant Sciences, Magnolia Medical Technologies and 28 more

    Contact details available

  • Tony Nguyen

    Hedge Fund, Venture Capital, Investor · United States

    Series BAdvertisingHealth CareGeneticsInvestment Management

    Portfolio: AveXis, Frequency Therapeutics, Roivant Sciences, Magnolia Medical Technologies and 28 more

    Contact details available

  • Alfred Yue

    Venture Capital · United States

    Health CareGeneticsWomen FoundedLife Science

    Portfolio: ENYO Pharma, Y-mAbs Therapeutics, NuCana, Histogenics and 63 more

    Contact details available

  • Hooman Shahlavi

    Hedge Fund, Venture Capital · United States

    Health CareGeneticsWomen FoundedInvestment Management

    Portfolio: ENYO Pharma, Y-mAbs Therapeutics, NuCana, Histogenics and 63 more

    Contact details available

  • Michael MontgomeryVerified

    Angel/Individual

    SeedHealth CareWomen FoundedBiotechnologyTherapeutics

    Portfolio: Athira Pharma

    Verified email available

  • Bruce Montgomery

    Angel/Individual

    SeedHealth CareHealthcare InnovationBiotechnologyTherapeutics

    Portfolio: Athira Pharma

    Contact details available

By investment stage

By location

Related industries

Most-backed portfolio companies

Frequently asked questions

How many Athira Pharma investors are on Angel Roster?

Angel Roster lists 18 Athira Pharma investors. 8 of them (44%) include a verified email address.

What types of investors are they?

The most common investor types are Venture Capital Firms (16), Hedge Funds (9) and Angel Investors (2). An investor can have more than one type, for example an angel who is also a venture partner.

Which stages do Athira Pharma investors invest in?

Among those that list a stage, the most common are Series B (8) and Seed (6).

Where are Athira Pharma investors based?

Most are based in the United States (15) and Canada (1).

Which companies have Athira Pharma investors backed?

The most-backed portfolio companies among them are Aerovate Therapeutics (9), Iterum Therapeutics (9), Edge Therapeutics (9), Inozyme (9) and Visen Pharmaceuticals (9).

How do I contact Athira Pharma investors?

Create a free Angel Roster account to search and filter all 18, then unlock verified emails and LinkedIn profiles on a paid plan. Every plan starts with a 3-day free trial.